Philips Respironics, a subsidiary of Philips based in Murrysville, Pennsylvania, recently announced the release of a new device for the treatment of chronic respiratory insufficiency disease. The new device, the BiPAP A40, was announced on World COPD Day 2012.
According to a press release by the company, the BiPAP A40 is a new bi-level, multi-modality ventilator with an automation ventilation system. The automated ventilation mode is designed to assist patients during the transition from a managed healthcare facility or hospital to a private residence.
The new ventilation mode is called the AVAPS-AE. Its automated mode can be used to guide physicians during the first stages of therapy. In addition, the system is designed to improve efficacy and comfort for a patient. By maintaining airway patency and delivering an accurate amount of air for a patient, the device can help stabilize a patient’s blood oxygen levels quickly and easily. In addition, the BiPAP A40 comes with a specialized battery module for portability. In addition to portability, the battery mode can be a valuable lifeline for a patient during a power outage.
In a prepared statement, the manager of Philips Home Healthcare Solutions, Mats Dalquist, said, “Philips is proud to be able to provide access to new and innovative solutions that improve quality of care for respiratory patients – both in hospital and at home.”